DDAH2 and coronary artery disorder: Genetic variations, particularly single nucleotide polymorphisms (SNPs) in genes nitric oxide synthase (NOS3) and dimethylarginine dimethylaminohydrolase 2​​​​​​​ (DDAH2), influence CAD susceptibility [3].